Dr. Sigurdur Y. Kristinsson, the Principal Investigator of iStopMM at the University of Iceland, will present to participants about IMF-led research in Iceland. Then, cyclists will take a tour of the ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible ...

Dr. Costa addresses community-based versus academic center care debates for complex patients requiring multiple therapy lines ...

Around 1,600 people a year in England with multiple myeloma are set to benefit from a new treatment option after we recommended belantamab mafodotin (also known as Blenrep and made by GSK).

A University of Calgary study led by members of the Arnie Charbonneau Cancer Institute, published in Nature Medicine, takes a ...

Investigators compared cancer-specific survival rates after synchronous vs metachronous metastasis in patients with surgically treated renal cell carcinoma (RCC).

Every day, 100 Americans are diagnosed with multiple myeloma, a cancer of the white blood cells in the bone marrow that ...

Every day, 100 Americans are diagnosed with multiple myeloma, a cancer of the white blood cells in the bone marrow that ...

This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...

New global research reveals complex links between diet types and cancer risks, including surprising findings for vegetarians ...

The FDA has granted fast track designation to OPN-6602, an investigational oral dual inhibitor of EP300 and CREB-binding ...

Dearbhla, mum to Oscar nominee Paul and musician Nell as well as a third child Donnacha, has opened up on how changing her ...